Hong Kong Investment Corporation Limited fully supports the 2026-27 Budget (February 2026)
(Hong Kong, 25th February) The Hong Kong Investment Corporation Limited (“HKIC”) fully supports the 2026-27 Budget (“Budget”) announced by the Financial Secretary. The Budget underscores the HKSAR Government (“Government”)’s strategic resolve to align closely with the national 15th Five-Year Plan and accelerate the nurturing of New Quality Productive Forces. As the Government’s professional investment arm, the HKIC will continue to leverage its distinctive approach of being market-oriented, industry-focused, and internationally connected to navigate with precision in the complex and changing global landscape, with a view to further enhancing Hong Kong’s long-term competitiveness and sustaining the momentum for high-quality economic development.
The Budget highlighted the significant progress of the HKIC’s strategy since it had come into full operation, placing emphasis on both investment and capital curation. The HKIC has invested in over 190 projects across key areas including Hard and Core Technology, Biotechnology, and New Energy and Green Technology, as well as the relevant applications. Driven by professional screening and strategic capital deployment, every Hong Kong dollar invested by the HKIC has successfully attracted over 8 Hong Kong dollars from long-term market capital. As of today, 10 portfolio companies have successfully listed in Hong Kong. Additionally, over 20 portfolio companies are planning to submit their listing applications in Hong Kong within this year.
The Budget mentioned that the HKIC will partner with regional and international capital and channel the capital into commercial property that aligns with Hong Kong’s industrial positioning. Ms Clara Chan, Chief Executive Officer of the HKIC, said, “By channeling regional and international long-term capital into high-quality commercial property projects, we will forge a pioneering and deep synergy between ‘Industry and Space’, enabling promising enterprises to make good use of these high-quality assets in Hong Kong. This type of property investment, which is closely aligned with the actual needs of enterprises, will enable effective resource optimisation and encourage businesses to take root in Hong Kong. In addition, this will continuously inject momentum into the local economy and provide international capital with room for medium-to-long-term capital appreciation, thereby bringing benefits to all parties involved.”
In response to the national and Hong Kong’s strategic demand for underlying technology of a new generation of chips, the Budget stated that the HKIC will actively promote research and development (“R&D”) and industrialisation of RISC-V technology through strategic investments and partnerships with leading enterprises, thereby building a RISC-V ecosystem in the Greater Bay Area. Ms Clara Chan noted, “The open-source nature of RISC-V is key to breaking down the limitations of closed-source architecture and achieving innovative transformation. By participating in the founding of the ‘Hong Kong RISC-V Alliance’, we are actively connecting the R&D strengths of the Greater Bay Area with opportunities for international collaborations. This facilitates the construction of an ecosystem for chip design and application, positioning Hong Kong to take a proactive role in the transformation of the global semiconductor industry chain.”
At the same time, the Budget mentioned that the Government will arrange for capital injection to the HKIC in a timely manner. The HKIC believes that this will further cement the robust foundation for our investment and industrial positioning. We will continue to play to our strength as Patient Capital with thought leadership and ability to channel other capital, bringing together the resources of international markets and accelerating the transformation and application of frontier technologies, thereby further propelling Hong Kong into a core global hub for patient and innovative capital.
The HKIC will remain steadfast in its dual mandate as Patient Capital, seeking medium-to-long-term financial return while leveraging its platform to connect capital, industry, talent, and opportunity through our extensive global network and deep, cross-sectoral collaboration. By doing so, the HKIC will transform Hong Kong’s advantages into tangible development momentum with a market-oriented, industry-focused, and internationally-connected perspective. Dedicated to becoming a core engine to drive industrial transformation, the HKIC will exert its influence in leading and bringing together investments to serve the national modernisation and high-quality development agenda, and to seize the pioneering and strategically important opportunities for Hong Kong’s future development.
– END –
About HKIC
The HKIC was established in 2022 as the Patient Capital institution wholly owned by and representing the HKSAR Government. It adopts an “Investment +” approach, seeking reasonable financial return in the medium to long term and at the same time creating and supporting the growth impetus with a view to contributing to Hong Kong’s economy and society.
The HKIC currently manages the “Hong Kong Growth Portfolio”, “Greater Bay Area Investment Fund”, “Strategic Tech Fund”, and “Co-Investment Fund”. At this stage, it is focusing on three key sectors, namely Hard and Core Technology, Biotech, and New Energy and Green Technology, as well as the relevant applications. Currently, the HKIC has invested in over 190 projects. Every Hong Kong dollar invested by the HKIC has attracted over 8 Hong Kong dollars from long-term capital for investment.